NICE recommends Kymriah® for routine NHS use, offering immense benefits for those with resistant B-...
Safety signals have sparked vital discussions on patient access to ATMPs, marking a pivotal moment i...
Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
Δ